Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Recipient : Isabelle Herter-Aeberli
Deal Size : Inapplicable
Deal Type : Inapplicable
Determination of Iron Absorption Mechanism From Ferrous Fumarate With GOS
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 24, 2019
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Recipient : Isabelle Herter-Aeberli
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Recipient : Isabelle Herter-Aeberli
Deal Size : Inapplicable
Deal Type : Inapplicable
Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 03, 2018
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Recipient : Isabelle Herter-Aeberli
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Recipient : Swiss Federal Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 30, 2017
Lead Product(s) : Ferrous Fumarate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Recipient : Swiss Federal Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
